Suchergebnisse - "Buclin, Thierry"

PubPharm (10)

1

Parametric Approaches in Population Pharmacokinetics

enthalten in: Journal of clinical pharmacology | 2022

von Guidi, M. | Csajka, C. | Buclin, T.

2

Comparison of Population Pharmacokinetics Based on Steady-State Assumption Versus Electronically Monitored Adherence to Lopinavir, Atazanavir, Efavirenz, and Etravirine : A Retrospective Study

enthalten in: Therapeutic drug monitoring | 2016

von Fuchs, A. | Rotzinger, A. | Cavassini, M. | +4

3

In Vivo Profiling and Distribution of Known and Novel Phase I and Phase II Metabolites of Efavirenz in Plasma, Urine, and Cerebrospinal Fluid

enthalten in: Drug metabolism and disposition: the biological fate of chemicals | 2016

von Aouri, M. | Barcelo, C. | Ternon, B. | +61

4

Successful efavirenz dose reduction guided by therapeutic drug monitoring

enthalten in: Antiviral therapy | 2011

von Fayet Mello, A. | Buclin, T. | Decosterd, L. | +8

5

Does tenofovir influence efavirenz pharmacokinetics?

enthalten in: Antiviral therapy | 2007

von Rotger, M. | Colombo, S. | Furrer, H. | +3

6

Orosomucoid (alpha1-acid glycoprotein) plasma concentration and genetic variants : effects on human immunodeficiency virus protease inhibitor clearance and cellular accumulation

enthalten in: Clinical pharmacology and therapeutics | 2006

von Colombo, S. | Buclin, T. | Décosterd, L. | +6

7

A case of voluntary intoxication with efavirenz and lamivudine

enthalten in: AIDS (London, England) | 2006

von Boscacci, R. | Buclin, T. | Furrer, H. | +1

8

Influence of CYP2B6 polymorphism on plasma and intracellular concentrations and toxicity of efavirenz and nevirapine in HIV-infected patients

enthalten in: Pharmacogenetics and genomics | 2005

von Rotger, M. | Colombo, S. | Furrer, H. | +8

9

Population pharmacokinetics and effects of efavirenz in patients with human immunodeficiency virus infection

enthalten in: Clinical pharmacology and therapeutics | 2003

von Csajka, C. | Marzolini, C. | Fattinger, K. | +5

10

Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1 : a pharmacogenetics study

enthalten in: Lancet (London, England) | 2002

von Fellay, J. | Marzolini, C. | Meaden, E. | +14

CommentIn: Lancet. 2002 Jun 15;359(9323):2114; author reply 2214-5. - PMID 12086787

1
[1]